GIM
TMDX icon

Granahan Investment Management’s Transmedics TMDX Stock Holding History

Granahan Investment Management’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-61,817
Closed -$9.71M – 206
2024
Q3 		$9.71M Sell
61,817
-9,792
-14% -$1.51M 0.38% 80
2024
Q2 		$10.8M Sell
71,609
-61,778
-46% -$7.41M 0.43% 74
2024
Q1 		$9.86M Sell
133,387
-13,349
-9% -$1.1M 0.35% 88
2023
Q4 		$11.6M Buy
146,736
+12,858
+10% +$776K 0.38% 81
2023
Q3 		$7.33M Buy
133,878
+14,184
+12% +$1.02M 0.26% 105
2023
Q2 		$10.1M Buy
119,694
+49,735
+71% +$3.81M 0.31% 88
2023
Q1 		$5.3M Buy
+69,959
New +$4.84M 0.16% 123

Other funds holding TMDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Granahan Investment Management's TMDX Position: Q4 2024 in Review

Granahan Investment Management sold out of Transmedics (TMDX) in Q4 2024, closing a stake of 61,817 shares — an estimated $9.71M sold.

Granahan Investment Management first reported a position in TMDX in Q1 2023 and held it in 7 quarters. The position peaked at $11.6M in Q4 2023. 314 funds tracked by Wall St. Rank hold TMDX as of Q4 2024.

  • Granahan Investment Management reported no remaining Transmedics position as of Q4 2024 after selling out during the quarter.
  • Granahan Investment Management sold 61,817 Transmedics shares in Q4 2024, an estimated $9.71M.
  • Granahan Investment Management first reported a position in Transmedics in Q1 2023 and held it in 7 quarters.
  • Granahan Investment Management's Transmedics position peaked at $11.6M in Q4 2023.
  • 314 funds tracked by Wall St. Rank held Transmedics as of Q4 2024.

Based on Granahan Investment Management's 13F filing for Q4 2024, filed 14 Feb 2025.